Pakistan Health News API

{
    "totalArticles": 61150,
    "articles": [
        {
            "id": "0f66b9c317195fc63f38a34da1dba25d",
            "title": "WHO issues guidelines on GLP-1 therapies for obesity treatment: Understanding the impact, safety considerations, and who can benefit",
            "description": "This week, the World Health Organization entered a new arena with its first global guideline on GLP-1 therapies for obesity treatment. Released on December 1, 2025, the document conditionally recommends drugs like semaglutide, liraglutide, and tirzepatide for adults with a BMI of 30 or higher-but only as part of a lifelong plan that pairs them with healthy diets, regular physical activity, and professional counseling. This comes at a time when over one billion people worldwide struggle with obesity a figure predicted to double by 2030-driving up deaths from heart disease, diabetes, and certain cancers while costing trillions in health expenses. WHO Director-General Dr. Tedros Adhanom Ghebreyesus called it a tool to treat obesity as the chronic disease it truly is-not a quick fix.",
            "content": "This week, the World Health Organization entered a new arena with its first global guideline on GLP-1 therapies for obesity treatment. Released on December 1, 2025, the document conditionally recommends drugs like semaglutide, liraglutide, and tirzep... [3381 chars]",
            "url": "https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/who-issues-guidelines-on-glp-1-therapies-for-obesity-treatment-understanding-the-impact-safety-considerations-and-who-can-benefit/photostory/125733037.cms",
            "image": "https://static.toiimg.com/thumb/msid-125733164,width-1070,height-580,imgsize-342746,resizemode-75,overlay-toi_sw,pt-32,y_pad-500/photo.jpg",
            "publishedAt": "2025-12-03T04:30:00Z",
            "lang": "en",
            "source": {
                "id": "9c931d3332c3a87c89b804230892aa64",
                "name": "The Times of India",
                "url": "https://timesofindia.indiatimes.com"
            }
        },
        {
            "id": "560e3c1eabb3e51f79faa01a34688a5f",
            "title": "Aids spreading fast in Khyber, warn health experts",
            "description": "Call for efforts to inform people about preventive measures.",
            "content": "KHYBER: Lack of awareness and lackluster response from the health authorities is resulting in rapid spread of Acquired Immunodeficiency Syndrome (Aids) among residents in different parts of Khyber, health experts told Dawn on Tuesday.\nThey said Khybe... [1988 chars]",
            "url": "https://www.dawn.com/news/1958945",
            "image": "https://i.dawn.com/large/2025/12/030925346ea05f8.webp",
            "publishedAt": "2025-12-03T03:35:47Z",
            "lang": "en",
            "source": {
                "id": "e7c51bc1b8daaa70cfd1f48e936fcc2b",
                "name": "Dawn",
                "url": "https://www.dawn.com"
            }
        },
        {
            "id": "110e5e3f839d23430231ed2bfce962e7",
            "title": "Aids spreading fast in Khyber, warn health experts",
            "description": "Call for efforts to inform people about preventive measures.",
            "content": "KHYBER: Lack of awareness and lackluster response from the health authorities is resulting in rapid spread of Acquired Immunodeficiency Syndrome (Aids) among residents in different parts of Khyber, health experts told Dawn on Tuesday.\nThey said Khybe... [1988 chars]",
            "url": "https://www.dawn.com/news/1958945/aids-spreading-fast-in-khyber-warn-health-experts",
            "image": "https://i.dawn.com/large/2025/12/030925346ea05f8.webp",
            "publishedAt": "2025-12-03T03:35:47Z",
            "lang": "en",
            "source": {
                "id": "e7c51bc1b8daaa70cfd1f48e936fcc2b",
                "name": "Dawn",
                "url": "https://www.dawn.com"
            }
        }
    ]
}